SEVERAL COMPANIES WORKING IN ORAL Solid Dosage (OSD) outsourcing enjoyed a solid-to-spectacular 2012.
What does OSD stand for?
OSD stands for Oral Solid Dosage (pharmaceutical use)
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of OSD
We have 179 other meanings of OSD in our Acronym Attic
- Operational System(s) Development
- Operational Systems Document
- Operations Services Division
- Operations Support Directive
- Operations Support Division (various locations)
- Optical Super Density
- Optical Systems Division (3M)
- Optimal Soft Decoding
- Optimum Successive Decoder
- Oral Sedation Dentistry
- Order of Saint Dominic
- Ordered Statistic Decoding
- Ordnance Supply Depot
- Oregon School for the Deaf
- Original Software Developer
- Ostersund, Sweden - Froesoe (Airport Code)
- Other Special District (Texas)
- Otomotiv Sanayicileri Derneði (Turkish Automotive Industrial Organization)
- Outside Door
- Over, Short and Damaged
Samples in periodicals archive:
is a Taiwan based emerging specialty pharmaceutical company dedicated to the development and manufacturing of oral solid dosage forms of generics including hormone, cytotoxic and soft-gel capsule products.
Washington, Oct 18 ( ANI ): A new medicated chewing gum has been developed for motion sickness, which could offer many advantages over conventional oral solid dosage forms.
Nasdaq:IPCI) (TSX:I), Toronto, a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- release and targeted-release oral solid dosage drugs, today provided an update on its research and development activities and achievement of a goal in relation to its Rexista(TM) abuse- deterrent formulations for opioid and narcotic drugs.
The facility will produce oral solid dosage products including tablets and capsules for treating conditions such as diabetes, hyperlipidemia, hypertension, peptic ulcers, psychiatric conditions, neurological and respiratory tract disorders.
is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs.
Toronto, (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, has announced that the staff of the Nasdaq Stock Market has granted the company an extension of the deadline to regain compliance with Nasdaq Listing Rule 5550(b), which requires companies listed on the Nasdaq Capital Market to maintain a minimum of $2,500,000 in shareholders' equity, $35,000,000 in market value of listed securities or $500,000 in net income from continuing operations.
The facility will be modified to become a packaging center for oral solid dosage tablets and capsules received from the company s manufacturing sites.